Cavatar
Cavatar is a biotechnology company located in La Jolla, CA, focused on improving drug performance through enhanced delivery. They combine antibody engineering and in vivo imaging techniques in stringent pre-clinical models of disease to visualize and quantify tissue targeting, delivery, processing, and therapeutic effects. Their precision delivery platform actively pumps targeting antibodies and attached cargo directly into diseased tissue, such as solid tumors, to enhance efficacy, reduce off-target toxicities, and improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Cavatar
505 Coast Boulevard South, Suite 209, La Jolla, CA 92037
Products
Precision Delivery Platform
A cellular transport system that pumps targeting antibodies and attached cargo directly into diseased tissue, enhancing drug efficacy and reducing off-target effects.
Precision Delivery Platform
A cellular transport system that pumps targeting antibodies and attached cargo directly into diseased tissue, enhancing drug efficacy and reducing off-target effects.
Caveolae-Specific Targeting Antibodies
Antibodies that enable therapeutic agents to penetrate rapidly and specifically into diseased tissues, such as tumors and fibrotic lung.
Caveolae-Specific Targeting Antibodies
Antibodies that enable therapeutic agents to penetrate rapidly and specifically into diseased tissues, such as tumors and fibrotic lung.
Pre-Clinical Disease Models
Stringent models that replicate human disease to visualize and quantify tissue targeting, delivery, and therapeutic events.
Pre-Clinical Disease Models
Stringent models that replicate human disease to visualize and quantify tissue targeting, delivery, and therapeutic events.
Precision Delivery Platform
A cellular transport system that pumps targeting antibodies and attached cargo directly into diseased tissue, enhancing drug efficacy and reducing off-target effects.
Precision Delivery Platform
A cellular transport system that pumps targeting antibodies and attached cargo directly into diseased tissue, enhancing drug efficacy and reducing off-target effects.
Caveolae-Specific Targeting Antibodies
Antibodies that enable therapeutic agents to penetrate rapidly and specifically into diseased tissues, such as tumors and fibrotic lung.
Caveolae-Specific Targeting Antibodies
Antibodies that enable therapeutic agents to penetrate rapidly and specifically into diseased tissues, such as tumors and fibrotic lung.
Pre-Clinical Disease Models
Stringent models that replicate human disease to visualize and quantify tissue targeting, delivery, and therapeutic events.
Pre-Clinical Disease Models
Stringent models that replicate human disease to visualize and quantify tissue targeting, delivery, and therapeutic events.
Services
Collaborative application of a caveolae-mediated delivery platform to improve tissue penetration and delivery of therapeutic and imaging agents for research and drug development programs.
Preclinical assessment service using stringent tumor and fibrotic lung models combined with high-resolution in vivo imaging to quantify delivery, processing, and therapeutic response.
Discovery service combining proteomic analysis and in vivo imaging to identify and validate disease-induced targets at blood–tissue interfaces for use in targeted delivery strategies.
Collaborative application of a caveolae-mediated delivery platform to improve tissue penetration and delivery of therapeutic and imaging agents for research and drug development programs.
Preclinical assessment service using stringent tumor and fibrotic lung models combined with high-resolution in vivo imaging to quantify delivery, processing, and therapeutic response.
Discovery service combining proteomic analysis and in vivo imaging to identify and validate disease-induced targets at blood–tissue interfaces for use in targeted delivery strategies.
Expertise Areas
- Targeted drug delivery
- Antibody engineering and conjugation
- Proteomic discovery and imaging
- Preclinical tumor and fibrotic lung modeling
Key Technologies
- Proteomic imaging
- In vivo molecular imaging
- Caveolae-mediated transcytosis targeting
- Antibody engineering
News & Updates
A scientific article published in Nature Medicine in September 2014 discussing caveolae and their role in drug delivery.
Our proteomic imaging discovery platform can be effective in identifying useful targets and probes for more ideal drug delivery.
Caveolae can have disease-induced delivery targets for pumping targeted agents inside tissue.
Antibodies can be used to target caveolae to deliver their attached cargo and penetrate deep inside tissue.
The caveolae pumping system can be efficient and effective in the vascular endothelium of diseased tissue.
A scientific article published in Nature Medicine in September 2014 discussing caveolae and their role in drug delivery.
Our proteomic imaging discovery platform can be effective in identifying useful targets and probes for more ideal drug delivery.
Caveolae can have disease-induced delivery targets for pumping targeted agents inside tissue.
Antibodies can be used to target caveolae to deliver their attached cargo and penetrate deep inside tissue.
The caveolae pumping system can be efficient and effective in the vascular endothelium of diseased tissue.